悦心健康(002162.SZ):子公司斯米克投資擬與關聯方合資設立投資公司
格隆匯7月9日丨悦心健康(002162.SZ)公佈,基於公司長遠戰略發展需要,為拓展公司在大健康產業的投資,加速推進公司在醫康養領域的佈局,提升可持續發展能力,公司全資子公司上海斯米克投資有限公司(以下簡稱"斯米克投資")擬與關聯方上海斯米克有限公司(以下簡稱"上海斯米克")簽署《合資協議》,共同投資設立上海悦心創智投資有限公司(暫定名,最終以市場監督管理局核准登記為準,以下簡稱"悦心創智"),作為公司進行醫康養等大健康產業鏈業務佈局的投資孵化平台,為公司儲備和培育新的戰略項目,使公司能夠及時把握產業的併購整合機會,增加新的投資機會和業績增長點。悦心創智註冊資本5,000萬元人民幣,其中斯米克投資擬出資2,000萬元人民幣,佔註冊資本的40%,上海斯米克擬出資3,000萬元人民幣,佔註冊資本的60%。
公司於2024年7月9日召開的第八屆董事會第九次會議審議通過了《關於全資子公司與關聯方合資設立投資公司暨關聯交易的議案》。鑑於交易對方上海斯米克是公司股東暨實際控制人李慈雄先生控制的企業,根據《深圳證券交易所股票上市規則》的相關規定,上述交易構成了關聯交易,公司董事李慈雄、宋源誠因在交易對方擔任董事職務而予以迴避表決。該項關聯交易已經公司獨立董事專門會議審議通過。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.